{"title":"Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein–protein interactions","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/CB/D3CB00222E","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D3CB00222E\" /></p></div><div><i><b>RSC Chem. Biol.</b></i>, 2024, <b>5</b>,198-208<br /><b>DOI</b>: 10.1039/D3CB00222E, Review Article</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Deanne Hayward, Andrew M. Beekman<br />Peptides are great starting points for drug discovery, but challenges remain in converting that potential to approved drugs. We review strategies for moving peptide features to small molecules, enabling small molecule drug development expertise.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Chem. Biol. latest articles","siteHash":"1843dfbfc0bf39b0fe9743f763f2ba4e6cb90d9c3732ca303b2e6e5daeb3deb0","entryHash":"c942c066e2ab5c661e0bdd84640f4b66322a94b942e96d36d551c0d571e6bca9","category":"Environment"}